Upcoming events.

Tohoku University
Jul
31
to Jul 31

Tohoku University

Overview

Innovation in healthcare and biotechnology is accelerating through the use of artificial intelligence, machine learning, and big data, alongside technological advances in regenerative medicine and gene delivery. The 2024 MIT Tokyo Life Science Symposium, co-hosted with LINK-J, will feature MIT faculty and MIT-connected startups speaking on the latest healthcare technologies that will enable new treatments for cancers, metabolic disorders, genetic diseases, and more.

Topics will include advances in DNA nanotechnology and synthetic biology, alongside the implications for pharmaceutical and synthetic biology applications. The role of sophisticated AI tools for identifying new drug candidates will be explored, as well as cutting-edge Machine Learning models that couple drug efficacy with synthesis and manufacturing considerations. A key focus will include biomanufacturing breakthroughs, from advanced reactor systems to the design of pilot-scale continuous manufacturing approaches for mRNA therapeutics.

Attendees can take advantage of this opportunity to explore collaboration potential and network with academic leaders, healthcare providers, and global industry partners.


Registration Fee:

- General Public: 20,000 JPY 
- ILP Member: Complimentary with membership
- LINK-J Member: Complimentary with membership

 

Please note that this event is an in-person event, and by registering, you are confirming your intention to join us physically.  

このイベントは対面形式で開催します。下記よりお申し込みの上、お越しください。


While there will be NO live streaming by ILP for this event, archived video recordings will be available to ILP members after the conference.

このイベントは、会場開催のみで、ILP によるライブ配信はございません。講演は録画され、ILP 会員の皆様は、後日 ILP Websiteでご覧いただけます。 





Agenda


ALL DATES/ TIMES LISTED BELOW ARE JAPAN STANDARD TIME (GMT +9)

全ての日程は、日本時間で表示されています。

Welcome & Introduction

Steven Palmer

Director, MIT Corporate Relations

Shunichi Takahashi, PhD

President and COO, Life Science Innovation Network Japan (LINK-J)​
Scientific Advisor and Fellow,  The Office of Innovation Industry-Academia Collaboration, Kyoto University

View Event →

Event Five
Jan
5
to Jan 7

Event Five

It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more. Or maybe you have a creative project to share with the world. Whatever it is, the way you tell your story online can make all the difference.

View Event →
Event Four
Jan
4
to Jan 6

Event Four

It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more. Or maybe you have a creative project to share with the world. Whatever it is, the way you tell your story online can make all the difference.

View Event →
Event Three
Jan
3
to Jan 5

Event Three

It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more. Or maybe you have a creative project to share with the world. Whatever it is, the way you tell your story online can make all the difference.

View Event →
Tokyo University
Jan
2
to Jan 4

Tokyo University

Overview

Innovation in healthcare and biotechnology is accelerating through the use of artificial intelligence, machine learning, and big data, alongside technological advances in regenerative medicine and gene delivery. The 2024 MIT Tokyo Life Science Symposium, co-hosted with LINK-J, will feature MIT faculty and MIT-connected startups speaking on the latest healthcare technologies that will enable new treatments for cancers, metabolic disorders, genetic diseases, and more.

Topics will include advances in DNA nanotechnology and synthetic biology, alongside the implications for pharmaceutical and synthetic biology applications. The role of sophisticated AI tools for identifying new drug candidates will be explored, as well as cutting-edge Machine Learning models that couple drug efficacy with synthesis and manufacturing considerations. A key focus will include biomanufacturing breakthroughs, from advanced reactor systems to the design of pilot-scale continuous manufacturing approaches for mRNA therapeutics.

Attendees can take advantage of this opportunity to explore collaboration potential and network with academic leaders, healthcare providers, and global industry partners.

Registration Fee:

- General Public: 20,000 JPY 
- ILP Member: Complimentary with membership
- LINK-J Member: Complimentary with membership

 

Please note that this event is an in-person event, and by registering, you are confirming your intention to join us physically.  

このイベントは対面形式で開催します。下記よりお申し込みの上、お越しください。

While there will be NO live streaming by ILP for this event, archived video recordings will be available to ILP members after the conference.

このイベントは、会場開催のみで、ILP によるライブ配信はございません。講演は録画され、ILP 会員の皆様は、後日 ILP Websiteでご覧いただけます。 

View Event →